Literature DB >> 17143251

c-Met inhibition.

Ravi Salgia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17143251

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  4 in total

1.  Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.

Authors:  Ute Schaeper; Regina Vogel; Jolanta Chmielowiec; Joerg Huelsken; Marta Rosario; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

2.  PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.

Authors:  Rajani Kanteti; Vidya Nallasura; Sivakumar Loganathan; Maria Tretiakova; Todd Kroll; Soundararajan Krishnaswamy; Leonardo Faoro; Philip Cagle; Aliya N Husain; Everett E Vokes; Deborah Lang; Ravi Salgia
Journal:  Lab Invest       Date:  2009-01-12       Impact factor: 5.662

3.  Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.

Authors:  Jianbo Yang; Matthew A Price; Gui Yuan Li; Menashe Bar-Eli; Ravi Salgia; Ramasamy Jagedeeswaran; Jennifer H Carlson; Soldano Ferrone; Eva A Turley; James B McCarthy
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

4.  Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

Authors:  Z Tang; R Du; S Jiang; C Wu; D S Barkauskas; J Richey; J Molter; M Lam; C Flask; S Gerson; A Dowlati; L Liu; Z Lee; B Halmos; Y Wang; J A Kern; P C Ma
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.